Burnier M - Search Results

1

Production and characterization of four anti-neuropeptide Y monoclonal antibodies.

Grouzmann E, Comoy E, Walker P, Burnier M, Bohuon C, Waeber B, Brunner H. Grouzmann E, et al. Among authors: burnier m. Hybridoma. 1992 Aug;11(4):409-24. doi: 10.1089/hyb.1992.11.409. Hybridoma. 1992. PMID: 1383123

2

Neurohormonal consequences of diuretics in different cardiovascular syndromes.

Burnier M, Brunner HR. Burnier M, et al. Eur Heart J. 1992 Dec;13 Suppl G:28-33. doi: 10.1093/eurheartj/13.suppl_g.28. Eur Heart J. 1992. PMID: 1362543 Review.

3

First-line pharmacological treatment of hypertension.

Burnier M, Waeber B, Brunner HR. Burnier M, et al. J Intern Med. 1992 Nov;232(5):381-8. doi: 10.1111/j.1365-2796.1992.tb00603.x. J Intern Med. 1992. PMID: 1453121 Review. No abstract available.

4

Antihypertensive therapy and mobilization of renal functional reserve.

Burnier M, Biollaz J, Steinhauslin F, Brouard R, Waeber B, Brunner HR. Burnier M, et al. Clin Invest Med. 1991 Dec;14(6):581-9. Clin Invest Med. 1991. PMID: 1686579 Review.

5

Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.

Mooser V, Nussberger J, Juillerat L, Burnier M, Waeber B, Bidiville J, Pauly N, Brunner HR. Mooser V, et al. Among authors: burnier m. J Cardiovasc Pharmacol. 1990 Feb;15(2):276-82. doi: 10.1097/00005344-199002000-00015. J Cardiovasc Pharmacol. 1990. PMID: 1689424 Clinical Trial.

6

[The treatment of arterial hypertension: which drug for which patient?].

Wafber B, Niederberger M, Nussberger J, Burnier M, Brunner HR. Wafber B, et al. Among authors: burnier m. Schweiz Rundsch Med Prax. 1992 Jan 14;81(3):32-6. Schweiz Rundsch Med Prax. 1992. PMID: 1732999 Review. French.

7

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.

Burnier M, Ganslmayer M, Perret F, Porchet M, Kosoglou T, Gould A, Nussberger J, Waeber B, Brunner HR. Burnier M, et al. Clin Pharmacol Ther. 1991 Aug;50(2):181-91. doi: 10.1038/clpt.1991.123. Clin Pharmacol Ther. 1991. PMID: 1831083 Clinical Trial.

8

Comparative cardiovascular effects of drugs used for hypertension.

Burnier M, Waeber B, Nussberger J, Brunner HR. Burnier M, et al. Drugs. 1990;39 Suppl 1:32-8. doi: 10.2165/00003495-199000391-00006. Drugs. 1990. PMID: 1968375 Review.

9

The role of neuropeptide Y in cardiovascular regulation.

Walker P, Grouzmann E, Burnier M, Waeber B. Walker P, et al. Among authors: burnier m. Trends Pharmacol Sci. 1991 Mar;12(3):111-5. doi: 10.1016/0165-6147(91)90518-w. Trends Pharmacol Sci. 1991. PMID: 2053188 Review.

10

[Cardiac insufficiency: how can we treat it?].

Burnier M, Waeber B, Brunner HR. Burnier M, et al. Rev Med Suisse Romande. 1991 May;111(5):425. Rev Med Suisse Romande. 1991. PMID: 2063057 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,169 results

Search Page

Filters